Janssen-Cilag International NV To Present Growing Set Of Oncology Data At The 2016 European Society For Medical Oncology (ESMO) Congress

BEERSE, Belgium--(BUSINESS WIRE)--Janssen-Cilag International NV today announced data from ten company-sponsored abstracts will be presented at the 2016 ESMO Congress in Copenhagen, Denmark, on the 9th and 10th October 2016. The data feature four Janssen medicines spanning multiple disease areas including prostate, urothelial and blood cancer, and showcase Janssen’s broad portfolio in oncology and commitment to patients.